Left atrial appendage closure devices. Their role in 2013.

Mangner, N; Sandri, M; Lurz, P; Dähnert, I; Schuler, G; Möbius-Winkler, S

Mangner, N; Sandri, M; Lurz, P; Dähnert, I; Schuler, G; Möbius-Winkler, S.

Affiliation

Mangner N; University of Leipzig, Leipzig, Germany.

Minerva Cardioangiol ; 61(2): 125-34, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23492596

Subject(s)

Embolic Protection Devices; Stroke/prevention & control; Thromboembolism/prevention & control; Anticoagulants/adverse effects; Anticoagulants/therapeutic use; Atrial Fibrillation/complications; Atrial Fibrillation/drug therapy; Atrial Fibrillation/surgery; Clinical Trials as Topic; Combined Modality Therapy; Embolic Protection Devices/statistics & numerical data; Embolic Protection Devices/trends; Fibrinolytic Agents/adverse effects; Fibrinolytic Agents/therapeutic use; Forecasting; Hemorrhage/chemically induced; Hemorrhage/prevention & control; Humans; Incidence; Prosthesis Design; Prosthesis Implantation/methods; Risk; Septal Occluder Device/statistics & numerical data; Septal Occluder Device/trends; Severity of Illness Index; Stroke/epidemiology; Stroke/etiology; Thromboembolism/epidemiology; Thromboembolism/etiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Stroke / Embolic Protection Devices Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Minerva Cardioangiol Year: 2013 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links